Bluejay Diagnostics, Inc.
Price Action
Technical Summary
DOWNTRENDBluejay Diagnostics, Inc. is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is weak (RS Rating: 8), showing significant lag compared to the market leaders. Earnings growth of 89% provides fundamental context to the price action. Investors should exercise caution due to high volatility (154% annualized), which requires wider risk management.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $1.90 | -0.67% | BELOW |
| 50 SMA | $1.93 | -2.32% | BELOW |
| 100 SMA | $2.46 | -23.08% | BELOW |
| 150 SMA | $4.13 | -54.21% | BELOW |
| 200 SMA | $4.57 | -58.66% | BELOW |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is BJDX in an uptrend right now?
BJDX has a trend score of 0/4 based on Minervini's Stage Analysis. Currently showing broken structure - 0 of 4 trend criteria are met.
Is BJDX overbought or oversold?
BJDX's RSI (14) is 50. The stock is in neutral territory, neither overbought nor oversold.
Is BJDX outperforming the market?
BJDX has a Relative Strength (RS) Rating of 8 out of 99. BJDX is currently lagging the broader market.
Where is BJDX in its 52-week range?
BJDX is trading at $1.89, which is 11% of its 52-week high ($16.68) and 7% above its 52-week low ($0.78).
How volatile is BJDX?
BJDX has a Beta of 0.89 and 52-week volatility of 154%. It's less volatile than the S&P 500 - generally more stable.